Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-01-05 @ 2:13 AM
Study NCT ID:
NCT02686593
Status:
COMPLETED
Last Update Posted:
2022-10-06
First Post:
2016-02-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML
Sponsor:
The University of Hong Kong
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-15
First Submit QC Date:
None
Study First Post Date:
2016-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-03
Last Update Post Date:
2022-10-06
Last Update Post Date Type:
ACTUAL